Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

Henry Schein (HSIC), a global healthcare distributor, is highlighted as a potential value stock by Zacks, currently holding a Zacks Rank #3 (Hold) with a VGM Score of A. The company's Value Style Score of A is supported by a forward P/E ratio of 14.73, and three analysts have increased their fiscal 2025 earnings estimates in the last 60 days, raising the Zacks Consensus Estimate to $4.87 per share; HSIC also has a 2.4% average earnings surprise.

Analysis

Henry Schein (HSIC), a global distributor of healthcare products and services operating in 33 countries, is presented by Zacks as a noteworthy stock for value-oriented investors. The company currently holds a Zacks Rank #3 (Hold), but importantly, it achieves a VGM Score of A and a Value Style Score of A. This strong value assessment is quantitatively supported by an attractive forward P/E ratio of 14.73. Further bolstering its profile, three analysts have revised their earnings estimates for fiscal 2025 upward within the last 60 days; the Zacks Consensus Estimate for this period now stands at $4.87 per share, reflecting an increase of $0, indicating stability or minor positive adjustments balancing out. Additionally, HSIC has demonstrated a consistent ability to outperform expectations, evidenced by an average earnings surprise of 2.4%. The combination of a #3 Rank with top-tier Style Scores (A or B) aligns with Zacks' guidance that such stocks possess upside potential and should be considered by investors.

Key Decisions for Investors

• Investors focused on value metrics should consider Henry Schein (HSIC) due to its A-rated Value and VGM Style Scores and a compelling forward P/E ratio of 14.73, despite its current Zacks #3 (Hold) rank.
• Monitor future earnings estimate revisions and any changes to HSIC's Zacks Rank, as these are highlighted as critical factors in assessing its potential, particularly for a 'Hold' rated stock with strong style scores.
• Given the positive individual analyst revisions for fiscal 2025 and consistent earnings surprise history, HSIC may warrant a place on a watchlist, especially if broader consensus estimates begin to reflect more significant upward momentum or if the overall Zacks Rank improves.